Featured Post from ChristianaCare

St. Georges Technical High School is first high school in the U.S. to use the Gene Editing Institute’s CRISPR in a Box Educational Toolkit™

Apr 8, 2021

4 min

Eric Kmiec, Ph.D

Toolkit is easily incorporated into any laboratory science course


Wilmington, Del., April 1, 2021 – St. Georges Technical High School in southern New Castle County, Delaware is the first high school in the United States to use ChristianaCare Gene Editing Institute’s innovative CRISPR in a Box Educational Toolkit™ in a science class.


CRISPR in a Box brings to life the much-heralded CRISPR gene editing technology – the “genetic scissors” that allow scientists to edit DNA. The toolkit is designed for educational sessions in secondary and post-secondary schools and is suitable for remote learning.


“Gene editing is the future of medicine,” said Eric Kmiec, Ph.D., director of ChristianaCare’s Gene Editing Institute. “Our partnership with the Delaware Department of Education will help cultivate the next generation of genetic scientists and enhance Delaware’s position as a leader in the biosciences.”


“We are thrilled that students at St. Georges Technical High School will be the first In the United States to experience a live demonstration of CRISPR gene editing using our Innovative CRISPR in a Box educational toolkit,” said Siobhan Hawthorne, Education and Community Outreach leader at ChristianaCare’s Gene Editing Institute. “This toolkit will provide STEM students with a visual understanding of how the exciting CRISPR technology can unlock medical treatments to improve lives.”



Delaware Secretary of Education Susan Bunting praised her department's partnership with ChristianaCare's Gene Editing Institute to develop the “Seeds of STEM” course that teaches high school students about gene editing.


“Gene editing approaches diseases in new ways and will have significant impact in the health care and agriscience fields,” Bunting said. “This is a great example of an industry and education partnership investing in youth by providing hands-on knowledge and skills around emerging technology.”


“We are so fortunate that ChristianaCare’s Gene Editing Institute reached out to our program to plan a high school ‘first’ opportunity with this new CRISPR experiment,” said Danya Espadas, one of the St. Georges biotech teachers. “Giving students the chance to use a cutting-edge, 21st century tool for medicine in their own high school lab – to have that technology at their fingertips – transcends what they see in a textbook or a video. By being able to do it themselves, it makes it real for them.”


Espada said the experiment focuses on editing a gene of a non-infectious E.coli bacteria to become resistant to an antibiotic, thereby allowing researchers to create a new class of antibiotics that cannot be overcome by bacteria that are gene resistant.


“We’re talking about eventually saving lives, here,” she said. “What can be more important than that?”



The tools in CRISPR in a Box have been designed based on the pioneering discoveries of the Gene Editing Institute that are currently being used to explore next-generation medical therapies and diagnostics for diseases, including lung cancer and sickle-cell anemia. Component items in the toolkit include the CRISPR/Cas complex, a target DNA molecule, a mammalian cell free extract and a synthetic DNA molecule.


All materials in the kit are safe, synthetic materials. There are no live cultures or viruses involved. The kit is meant to provide a hands-on demonstration of CRISPR’s capabilities, and not allow for manipulations of living organisms.


“The kit is easy and fun to use,” said Kristen Pisarcik, research assistant at the Gene Editing Institute who has taught students at Delaware Technical Community College which first used the toolkit. “In a short period of time students will reliably and successfully complete the laboratory activity and be able to see the results of gene editing,” she said.



Since the foundations of the kit touch upon key themes in biology, it can be readily incorporated into practically any science or biology course with a laboratory component,


“One of the beauties of CRISPR in a Box is that there is no need to purchase specialized equipment. If a teaching lab can support bacterial cultivation, it can perform the in vitro gene editing lab activity,” Pisarcik said.


CRISPR in a Box is the evolution of a partnership between the Gene Editing Institute, Delaware Technical Community College and Rockland Immunochemicals that began in 2017 with a National Science Foundation grant to develop the first-ever gene editing curriculum for community college students.


Video and photo collection of first class in U.S. to use CRISPR in a Box™ educational gene editing toolkit.


About ChristianaCare’s Gene Editing Institute
The Gene Editing Institute, a worldwide leader in CRISPR gene editing technology and the only institute of its kind based within a community health care system, takes a patient-first approach in all its research to improve the lives of people with life-threatening disease. Since 2015, researchers at the Gene Editing Institute have been involved in several ground-breaking firsts in the field, including the development of the first CRISPR gene editing tool to allow DNA repairs outside the human cell which will rapidly speed therapies to patients and a unique version of CRISPR called EXACT that reduces the number of off-target edits to other areas of the genome, which is vital for further research and patient applications. Its researchers are currently developing a patient trial for lung cancer using CRISPR and employing the technology to combat the COVID-19 pandemic.

About the biotech program St. Georges Technical High School
The Biotech career program of study at St. Georges Technical High School is the first such program offered in a Delaware high school. With two teachers and approximately 100 students in grades 10-12, the program presents advanced content in biology and chemistry with opportunities for students to learn basic laboratory techniques and procedures and to maintain and operate common instruments and equipment used in a biotechnology laboratory. St. Georges is a comprehensive career and technical high school with 1,100 students who study in one of 16 different career pathways.


Connect with:
Eric Kmiec, Ph.D

Eric Kmiec, Ph.D

Executive Director and Chief Scientific Officer, The Gene Editing Institute

Dr. Kmiec, a pioneer in the field, has achieved several ground-breaking firsts in CRISPR gene editing.

Gene EditingBiomedical ResearchMolecular Medicine
Powered by

You might also like...

Check out some other posts from ChristianaCare

ChristianaCare Advances New Health Campus in Camden, Delaware to Close Care Gaps featured image

3 min

ChristianaCare Advances New Health Campus in Camden, Delaware to Close Care Gaps

ChristianaCare has taken another major step to expand access to high quality care across Delaware by submitting a Notice of Intent to the Delaware Health Resources Board to develop a new health campus in Camden. Like the Georgetown campus announced in February, the proposed campus will include a health center and a neighborhood hospital and is part of the $865 million statewide commitment announced last July. “For many people in central Delaware, getting timely emergency or specialty care can still mean long drives or long waits,” said Janice E. Nevin, M.D., MPH, president and CEO of ChristianaCare. “We are investing in facilities that bring care closer to where people live. This campus reflects our commitment to ensuring every Delawarean, no matter their ZIP code, can count on timely, compassionate, high-quality care close to home.” Closing Care Gaps in Central and Southern Delaware The approximately 38,000‑square‑foot Camden campus will be located on the west side of Route 13, just south of Lochmeath Way. It is expected to open in late 2028 or early 2029 and will bring primary care, specialty care and outpatient services together in one location, supported by eight emergency department beds and eight inpatient beds. The project will create 83 new jobs for the community, including 60 positions at the neighborhood hospital and 23 at the health center. Kent and Sussex counties are both designated as Medically Underserved Areas by the Health Resources and Services Administration. At the same time, the region is growing quickly. By 2030, the population in central and southern Delaware is expected to increase by 8 percent, with residents aged 65 and older growing even faster, by 22 percent. Shortages in primary care, behavioral health and specialty services have forced many residents to travel long distances for care. The Camden campus will help change that by bringing essential services closer to home. Expanding Capacity on a Strong Foundation The Camden campus represents a $58.1 million investment and reflects ChristianaCare’s focus on access, coordination and community need. ChristianaCare already provides a broad range of services in Kent County, including primary care, specialty care, behavioral health, rehabilitation, home health, hospice and virtual care. The Camden campus will build on this foundation by increasing capacity and making care more convenient as demand grows. Partnering to Deliver Care Close to Home ChristianaCare is partnering with Emerus Holdings, Inc. on the neighborhood hospital component. Emerus is the nation’s leading developer of this model, with 49 acute care facilities across the country. “Communities are stronger when people can depend on care close to home,” said Vic Schmerbeck, CEO of Emerus Holdings, Inc. “We are proud to partner with ChristianaCare to deliver a neighborhood hospital that provides high quality care in a setting designed around the needs of the community.” Growing Access Across the Region The ChristianaCare Georgetown campus is planned for 20769 DuPont Boulevard at an estimated cost of $65.1 million. ChristianaCare is also expanding this innovative care model beyond Delaware. In July 2025, the system opened a neighborhood hospital at its West Grove Campus in southern Chester County, Pennsylvania. Additional campuses are planned in Springfield and Aston in Delaware County, Pennsylvania.

ChristianaCare Forms Joint Venture For Cardiovascular Ambulatory Surgery Center featured image

4 min

ChristianaCare Forms Joint Venture For Cardiovascular Ambulatory Surgery Center

ChristianaCare, Cardiovascular Physicians of Delaware and its partner organization, US Health Partners, have formed a joint venture to establish a new cardiovascular ambulatory surgery center in Newark. This new facility will be launched through the ChristianaCare Atlas ASC partnership. This is a pivotal moment showcasing the power of a local health system, strength of a national ASC management company, and expert community-based physicians working together to deliver a lower cost, easy-to-access model of care to our community. “The ChristianaCare Cardiovascular Surgery Center at Newark represents a deep partnership between ChristianaCare and community cardiovascular experts who are truly committed to caring for this region,” said Kert F. Anzilotti, M.D., MBA, chief physician executive and president of The Medical Group at ChristianaCare. “By working side by side with trusted community physicians, we are aligning expertise and decision making to strengthen heart care across the region and ensure it continues to evolve with the needs of the people we serve.” “By expanding access to outpatient heart care, we can reduce wait times, improve the patient experience and lower the overall cost of care—while using our hospital resources more wisely and preserving capacity for patients who need complex or urgent cardiac services,” Anzilotti added. “With over 30 years of providing cardiac care to Delaware residents, we are proud to collaborate on this center,” said Brian Sarter, M.D., president of Cardiovascular Physicians of Delaware. For patients, this is about getting the right care, in the right place, at the right time. Patients will receive specialized heart care in a focused setting designed for same day procedures, with a smoother experience, faster recovery and seamless coordination with hospital care if it’s ever needed.” “This joint venture brings together ChristianaCare and Cardiovascular Physicians of Delaware’s strong clinical leadership and a proven outpatient care model,” said Aaron Snyder, M.D., chief executive officer of US Health Partners. “Our aim is to build and run a center that is efficient, reliable and patient-focused from day one, so physicians can focus on care and patients can count on a high-quality same-day experience close to home.” Reducing the Cost of Heart Care Ambulatory surgery centers lower the cost of heart care by safely moving appropriate procedures out of the hospital and into a more efficient outpatient setting. Most patients return home the same day, while hospitals preserve capacity for complex and urgent cases. As reported in Ambulatory Surgery Center News, outpatient procedures performed in ambulatory surgery centers cost 30 to 40 percent less than the same care delivered in hospitals, improving access and efficiency as demand for heart care continues to grow. The move also frees up limited hospital resources to better care for people with more complex or urgent cardiovascular needs. Meeting a Growing Need for Heart Care Heart disease remains the leading cause of death in Delaware, and demand for cardiovascular care is rising. According to the Delaware Population Consortium, the number of New Castle County residents age 65 and older is projected to increase by 23 percent by 2035, increasing pressure on cardiovascular services. Forecasts show outpatient heart and vascular procedures could reach nearly 10,800 annually for New Castle County residents by 2029 and more than 24,000 across the broader region, according to health care analytics firm Sg2. At the same time, hospital operating room capacity remains limited. Cardiovascular Physicians of Delaware’s many decades of experience in Newark and across the state positioned the group as a natural fit for the collaboration. Focused on Same Day Cardiovascular Care Expected to open in late 2027, the nearly 9,000 square foot center will be located on the second floor of the HealthCare Center at Christiana, across from Christiana Hospital. The center will focus exclusively on outpatient heart and vascular procedures. Services will include diagnostic heart catheterizations, coronary and peripheral vascular interventions, ablation procedures, pacemaker/ implantable defibrillator implantations and other minimally invasive cardiovascular procedures. Hospital based cardiac care will continue to be available for patients who need inpatient treatment, emergency care or more complex services. Other Details The project will cost an estimated $9.3 million and is expected to create 14 full time jobs across clinical, administrative, leadership and support roles. The facility represents an additional investment beyond ChristianaCare’s previously announced $865 million commitment to Delaware, reinforcing the organization’s focus on expanding services and improving health outcomes statewide. Key features of the surgery center include two new cardiac catheterization/ electrophysiology labs, dedicated pre operative and post anesthesia care space and on site sterile processing and administrative areas. Atlas Healthcare Partners will manage and operate the center, while Cardiovascular Physicians of Delaware will provide clinical oversight and perform outpatient surgical cases. ChristianaCare and Atlas Healthcare Partners formed the joint venture in 2024 to build an ambulatory surgery center network across the Mid-Atlantic region.

Union Hospital Earns Healthgrades 2026 Patient Safety Excellence Award for Second Consecutive Year featured image

1 min

Union Hospital Earns Healthgrades 2026 Patient Safety Excellence Award for Second Consecutive Year

Union Hospital has once again been ranked among the top 10% of hospitals nationwide, earning the 2026 Healthgrades Patient Safety Excellence Award™ for the second year in a row. In a landscape where many hospitals struggle to maintain consistency, Union Hospital is delivering a sustained streak of high reliability, driven by disciplined safety practices and a culture that puts patient protection first. Campus president Joan Pirrung captures it well: “Our caregivers are relentless about safety. Achieving this honor two years in a row shows the unwavering commitment they bring to every patient, every day.” At the heart of this repeat achievement is a team of caregivers who’ve built a culture where safety isn’t a program—it’s a daily practice. If you’re interested in the story behind these results, I can connect you with campus president Joan Pirrung for additional insight or interviews.

View all posts
Powered by